Viewing Study NCT05815303


Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2026-01-02 @ 3:28 AM
Study NCT ID: NCT05815303
Status: RECRUITING
Last Update Posted: 2023-04-18
First Post: 2023-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module